MA23838A1 - Solution aqueuse d'interferon x - Google Patents

Solution aqueuse d'interferon x

Info

Publication number
MA23838A1
MA23838A1 MA24195A MA24195A MA23838A1 MA 23838 A1 MA23838 A1 MA 23838A1 MA 24195 A MA24195 A MA 24195A MA 24195 A MA24195 A MA 24195A MA 23838 A1 MA23838 A1 MA 23838A1
Authority
MA
Morocco
Prior art keywords
interferon
aqueous solution
aqueous
solution
Prior art date
Application number
MA24195A
Other languages
English (en)
Inventor
Delterzo Sabino
Gross Gunter
Kandakuri Kumar Saran
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA23838A1 publication Critical patent/MA23838A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
MA24195A 1995-04-06 1996-04-01 Solution aqueuse d'interferon x MA23838A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95105166 1995-04-06

Publications (1)

Publication Number Publication Date
MA23838A1 true MA23838A1 (fr) 1996-12-31

Family

ID=8219166

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24195A MA23838A1 (fr) 1995-04-06 1996-04-01 Solution aqueuse d'interferon x

Country Status (32)

Country Link
US (1) US5762923A (fr)
EP (1) EP0736303B1 (fr)
JP (1) JP2758154B2 (fr)
KR (1) KR100212346B1 (fr)
CN (1) CN1066065C (fr)
AR (1) AR002932A1 (fr)
AT (1) ATE183650T1 (fr)
AU (1) AU685356B2 (fr)
BR (1) BR9601276A (fr)
CA (1) CA2172664C (fr)
CO (1) CO4750807A1 (fr)
CY (1) CY2194B1 (fr)
CZ (1) CZ287626B6 (fr)
DE (1) DE69603894T2 (fr)
DK (1) DK0736303T3 (fr)
ES (1) ES2136910T3 (fr)
GR (1) GR3031775T3 (fr)
HK (1) HK1012232A1 (fr)
HU (1) HU227643B1 (fr)
IL (1) IL117752A (fr)
MA (1) MA23838A1 (fr)
MY (1) MY113594A (fr)
NO (1) NO316801B1 (fr)
NZ (1) NZ286300A (fr)
PE (1) PE38897A1 (fr)
PL (1) PL183873B1 (fr)
RU (1) RU2113845C1 (fr)
SA (1) SA96160728B1 (fr)
SG (1) SG52806A1 (fr)
TR (1) TR199600287A2 (fr)
TW (1) TW426523B (fr)
ZA (1) ZA962553B (fr)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5951974A (en) * 1993-11-10 1999-09-14 Enzon, Inc. Interferon polymer conjugates
TW517067B (en) 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
CA2275890C (fr) * 1996-12-24 2011-11-01 Biogen, Inc. Formulations liquides stables d'interferon
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
HU228877B1 (en) * 1998-03-26 2013-06-28 Merck Sharp & Dohme Formulations for stabilization of peg-interferon alpha conjugates and method for preparation such formulations
US6180096B1 (en) 1998-03-26 2001-01-30 Schering Corporation Formulations for protection of peg-interferon alpha conjugates
JP2002510653A (ja) * 1998-04-03 2002-04-09 カイロン コーポレイション 緩衝剤としてコハク酸を含有する注射可能なｉｇｆ処方物
TWI277424B (en) 1998-05-15 2007-04-01 Schering Corp Combination therapy for eradicating detectable NCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection
AU767131B2 (en) * 1998-06-08 2003-10-30 F. Hoffmann-La Roche Ag Use of PEG-IFN-alpha and ribavirin for the treatment of chronic hepatitis C
US20030166525A1 (en) 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
AU776823B2 (en) † 1998-07-23 2004-09-23 Ares Trading S.A. FSH and FSH variant formulations, products and methods
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
DK1588716T3 (da) 1998-08-06 2011-05-23 Mountain View Pharmaceuticals Peg-uratoxidase-konjugater og anvendelse deraf
CA2356010A1 (fr) * 1998-12-22 2000-06-29 Schering Corporation Traitement des infections du virus de l'hepatite c avec interleukine-10
US6914128B1 (en) 1999-03-25 2005-07-05 Abbott Gmbh & Co. Kg Human antibodies that bind human IL-12 and methods for producing
US6923966B2 (en) 1999-04-08 2005-08-02 Schering Corporation Melanoma therapy
US6362162B1 (en) 1999-04-08 2002-03-26 Schering Corporation CML Therapy
PE20010027A1 (es) 1999-04-08 2001-02-05 Schering Corp Uso de interferon alfa pegilado en pacientes con melanoma
US6605273B2 (en) 1999-04-08 2003-08-12 Schering Corporation Renal cell carcinoma treatment
KR100399156B1 (ko) * 1999-11-19 2003-09-26 주식회사 엘지생명과학 α-인터페론의 용액제형
CN1175901C (zh) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 一种稳定的干扰素水溶液
AU2001259063A1 (en) 2000-04-12 2001-10-30 Human Genome Sciences, Inc. Albumin fusion proteins
US7208167B2 (en) * 2000-08-07 2007-04-24 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis C with thymosin and peptide combination therapy
PT1343518E (pt) 2000-11-07 2009-08-03 Novartis Vaccines & Diagnostic Composições de interferão estabilizadas
US8551469B2 (en) 2001-02-28 2013-10-08 Superlab Far East Limited Treatment of tumors and viral diseases with recombinant interferon alpha
CN1245215C (zh) 2001-02-28 2006-03-15 四川省生物工程研究中心 重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂
JP2002265383A (ja) * 2001-03-14 2002-09-18 Mitsubishi Pharma Corp インターフェロンα注射用液状製剤
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
WO2002083165A1 (fr) * 2001-04-10 2002-10-24 Sumitomo Pharmaceuticals Co., Ltd. Preparations stables destinees a etre injectees
LT4947B (lt) 2001-09-26 2002-08-26 Biotechnologijos Institutas Interferono alfa farmacinė kompozicija
EP1463751B1 (fr) 2001-12-21 2013-05-22 Human Genome Sciences, Inc. Proteines hybrides d'albumine
CN100411683C (zh) 2002-05-21 2008-08-20 阿斯比奥制药株式会社 含有生长素释放肽的药物组合物
PT1610822E (pt) 2003-04-02 2011-01-05 Ares Trading Sa Formulações farmacêuticas líquidas ou liofilizadas de fsh e/ou lh em conjunto com o surfactante não iónico poloxâmero 188 e um agente bacteriostático
TWI272948B (en) * 2003-05-01 2007-02-11 Ares Trading Sa HSA-free stabilized interferon liquid formulations
AR044302A1 (es) * 2003-05-13 2005-09-07 Ares Trading Sa Formulaciones con proteinas liquidas estabilizadas en recipientes farmaceuticos
US7740884B2 (en) 2003-06-20 2010-06-22 Ares Trading S.A. Freeze-dried FSH/LH formulations
DE10333317A1 (de) * 2003-07-22 2005-02-17 Biotecon Therapeutics Gmbh Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
AR045258A1 (es) * 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion
US7585647B2 (en) 2003-08-28 2009-09-08 Guangwen Wei Nucleic acid encoding recombinant interferon
JP2007519422A (ja) 2004-02-02 2007-07-19 アンブレツクス・インコーポレイテツド 修飾されたヒト四螺旋バンドルポリペプチド及びそれらの使用
ZA200609412B (en) 2004-05-17 2008-07-30 Ares Trading Sa Hydrogel interferon formulations
US7731948B2 (en) * 2004-06-01 2010-06-08 Ares Trading S.A. Stabilized interferon liquid formulations
CA2567309A1 (fr) * 2004-06-01 2005-12-15 Ares Trading S.A. Procede de stabilisation de proteines
JP4971160B2 (ja) 2004-08-12 2012-07-11 シェーリング コーポレイション 安定するｐｅｇ化インターフェロン処方物
EP1800689B1 (fr) * 2004-08-24 2016-12-28 Daiichi Sankyo Company, Limited Préparation liquide d'un peptide physiologiquement actif
SI3321359T1 (sl) 2005-04-11 2021-07-30 Horizon Pharma Rheumatology Llc Variantne oblike urat oksidaze in uporaba le-teh
ES2302402B1 (es) 2005-06-16 2009-05-08 Proyecto De Biomedicina Cima, S.L. Uso de una citoquina de la familia de interleuquina-6 en la preparacion de una composicion para administracion combinada con interferon-alfa.
EP1916997B1 (fr) * 2005-08-05 2018-04-18 Amgen Inc. Formulations pharmaceutiques de protéine aqueuse stable et leur préparation
CU23432B6 (es) 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras
WO2008026044A2 (fr) * 2006-08-31 2008-03-06 Wockhardt Research Centre Compositions pharmaceutiques de bupropion
CN104524567A (zh) 2007-01-16 2015-04-22 阿布维公司 用于治疗银屑病的方法
WO2008145323A1 (fr) * 2007-05-31 2008-12-04 F. Hoffmann-La Roche Ag Formulation pharmaceutique comprenant des interférons
EP2196475B1 (fr) * 2007-09-04 2012-06-06 Biosteed Gene Expression Tech. CO., LTD. INTERFERON ALPHA 2a MODIFIÉ PAR POLYETHYLÈNEGLYCOL, SON PROCESSUS DE SYNTHÈSE ET SON APPLICATION
PL2186830T3 (pl) * 2007-09-04 2012-09-28 Biosteed Gene Expression Tech Co Ltd Interferon alfa 2b zmodyfikowany glikolem polietylenowym, jego wytwarzanie i zastosowanie
US8216571B2 (en) * 2007-10-22 2012-07-10 Schering Corporation Fully human anti-VEGF antibodies and methods of using
EP2234645B1 (fr) 2007-12-20 2012-05-02 Merck Serono S.A. Formulations de peg-interféron-bêta
MX2010013759A (es) 2008-06-13 2011-05-25 Proyecto Biomedicina Cima Sl Conjugados para la administracion de compuestos biologicamente activos.
JP2012502906A (ja) * 2008-09-17 2012-02-02 ネクター セラピューティックス オリゴマー−プロテアーゼ阻害剤コンジュゲート
HUP1200205A3 (en) 2009-06-25 2012-09-28 Savient Pharmaceuticals Method and kits for perdicting infusion reaction risk and antibody-mediated low of response by monitoring serum uric acid during pegylated uricare therapy
CN102101886A (zh) 2009-12-18 2011-06-22 四川辉阳生命工程股份有限公司 构象改变的重组干扰素晶体、其三维结构及应用
RU2447083C1 (ru) * 2010-07-20 2012-04-10 Закрытое Акционерное Общество "Биокад" НОВЫЙ ФУНКЦИОНАЛЬНО АКТИВНЫЙ ВЫСОКООЧИЩЕННЫЙ СТАБИЛЬНЫЙ КОНЪЮГАТ ИНТЕРФЕРОНА α С ПОЛИЭТИЛЕНГЛИКОЛЕМ, ПРЕДСТАВЛЕННЫЙ ОДНИМ ПОЗИЦИОННЫМ ИЗОМЕРОМ ПЭГ-NαH-ИФН, С УМЕНЬШЕННОЙ ИММУНОГЕННОСТЬЮ, С ПРОЛОНГИРОВАННЫМ БИОЛОГИЧЕСКИМ ДЕЙСТВИЕМ, ПРИГОДНЫЙ ДЛЯ МЕДИЦИНСКОГО ПРИМЕНЕНИЯ, И ИММУНОБИОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ
KR101303388B1 (ko) 2010-10-26 2013-09-03 한미사이언스 주식회사 지속형 인터페론 알파 결합체의 액상 제제
CN102526758B (zh) * 2012-02-23 2013-02-13 北京三元基因工程有限公司 一种聚乙二醇化干扰素稳定的水溶液
TWI718086B (zh) 2013-01-07 2021-02-11 英屬維爾京群島商遠東超級實驗室有限公司 通過干擾素的經皮和/或經粘膜給藥治療骨癌、皮膚癌、皮下癌、粘膜癌和/或粘膜下癌的方法和組合物
US9388239B2 (en) 2014-05-01 2016-07-12 Consejo Nacional De Investigation Cientifica Anti-human VEGF antibodies with unusually strong binding affinity to human VEGF-A and cross reactivity to human VEGF-B
WO2016046101A1 (fr) * 2014-09-23 2016-03-31 F. Hoffmann-La Roche Ag Formulations stables, exemptes d'alcool benzylique, d'une solution aqueuse contenant de l'interféron de type alpha
RU2768656C1 (ru) * 2021-09-10 2022-03-24 Илья Александрович Марков Противовирусное средство в жидкой форме и способ его приготовления

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61277633A (ja) * 1985-05-31 1986-12-08 Toray Ind Inc インタ−フエロン組成物
EP0284249A1 (fr) * 1987-03-13 1988-09-28 Interferon Sciences, Inc. Composition lyophilisée de lymphokine
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
KR900701310A (ko) * 1988-11-14 1990-12-01 오스카 아끼히꼬 인터페론 경비투여용 제제
JPH0651642B2 (ja) * 1988-11-14 1994-07-06 大塚製薬株式会社 インターフェロン経鼻投与用製剤
CA2033714A1 (fr) * 1990-01-25 1991-07-26 Alberto Ferro Preparations pharmaceutiques
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5382657A (en) * 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
IL109350A (en) * 1993-05-12 2001-01-28 Genentech Inc Stable liquid preparations of gamma interferon

Also Published As

Publication number Publication date
US5762923A (en) 1998-06-09
EP0736303B1 (fr) 1999-08-25
HUP9600857A3 (en) 1998-01-28
NZ286300A (en) 1997-05-26
AU685356B2 (en) 1998-01-15
ATE183650T1 (de) 1999-09-15
NO961322D0 (no) 1996-04-01
CA2172664A1 (fr) 1996-10-07
MY113594A (en) 2002-04-30
PL183873B1 (pl) 2002-07-31
CN1141808A (zh) 1997-02-05
PE38897A1 (es) 1997-10-04
BR9601276A (pt) 1998-01-13
TR199600287A2 (tr) 1997-03-21
SG52806A1 (en) 1998-09-28
TW426523B (en) 2001-03-21
DE69603894D1 (de) 1999-09-30
HUP9600857A2 (en) 1997-08-28
NO316801B1 (no) 2004-05-18
JPH08283176A (ja) 1996-10-29
HU9600857D0 (en) 1996-05-28
IL117752A (en) 2000-11-21
GR3031775T3 (en) 2000-02-29
CA2172664C (fr) 2000-10-03
SA96160728B1 (ar) 2005-05-04
KR100212346B1 (ko) 1999-08-02
DK0736303T3 (da) 2000-01-10
EP0736303A3 (fr) 1997-02-26
IL117752A0 (en) 1996-08-04
ES2136910T3 (es) 1999-12-01
CZ99496A3 (en) 1996-10-16
CO4750807A1 (es) 1999-03-31
JP2758154B2 (ja) 1998-05-28
CN1066065C (zh) 2001-05-23
EP0736303A2 (fr) 1996-10-09
RU2113845C1 (ru) 1998-06-27
CZ287626B6 (en) 2001-01-17
ZA962553B (en) 1996-10-07
AU5044696A (en) 1996-10-17
PL313655A1 (en) 1996-10-14
KR960037063A (ko) 1996-11-19
AR002932A1 (es) 1998-05-27
HU227643B1 (en) 2011-10-28
CY2194B1 (en) 2002-11-08
DE69603894T2 (de) 2000-04-20
HK1012232A1 (en) 1999-07-30
NO961322L (no) 1996-10-07

Similar Documents

Publication Publication Date Title
MA23838A1 (fr) Solution aqueuse d'interferon x
MC2106A1 (fr) Derives d'aminoacides
BR9510256A (pt) Derivados de ácido 3-aril-tetrônico
MC2103A1 (fr) Derives d'aminoacides
DE69507842T2 (de) Wässrige microemulsionspolymerisation von tetrafluorethylen
DE69605444D1 (de) Entwässerung von wässrigen suspensionen
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
DE59609043D1 (de) Feste Lösungen von 1,4-Diketopyrrolopyrrolen
MA23133A1 (fr) Derives d'acide d'acyloxyhexanoique .
DE59504988D1 (de) Niedrigviskose wässrige konzentrate von betaintensiden
FR2735986B3 (fr) Prolongateur d'haltere
FR2769017B1 (fr) Concentres aqueux d'alkyl-betaine basse viscosite
ITRM940334A0 (it) Reiezione di "clutter" utilizzando connettivita
UA1629S (uk) Набір фестонів "веснянка-5"
FR2736832B1 (fr) Agent potentialisateur de l'interferon-gamma
ITTO950129V0 (it) "cornice predisposta per l'illuminazione di ambienti, applicata a qua-dri e/o a specchiere"
FR2647300B1 (fr) Variete d'hypoestes sanguinolenta " 1189 "
ES1020655Y (es) "prenda de aspecto cambiante"
KR970029596U (ko) 윈도우의 시야확보장치
ITMI930218A1 (it) Derivato peptidico della rimantadina di attivita' immunomodulante
ITRM950072V0 (it) Brevetto "mascia" (maglia-sciarpa)
UA1496S (uk) Набір етикеток "зубровка"
UA1498S (uk) Набір етикеток "сумська горобинова"
UA1904S (uk) Набір етикеток "недригайлівська"
UA1497S (uk) Набір етекеток "ярославна"